Repro-Med Systems, Inc. (NASDAQ:REPR) Director Joseph M. Jr. Manko acquired 32,500 shares of the stock in a transaction that occurred on Monday, October 10th. The stock was purchased at an average price of $0.43 per share, with a total value of $13,975.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of Repro-Med Systems, Inc. (NASDAQ:REPR) traded down 2.33% during mid-day trading on Tuesday, reaching $0.42. The company had a trading volume of 14,500 shares. The company has a market cap of $15.95 million and a price-to-earnings ratio of 84.00. Repro-Med Systems, Inc. has a 52-week low of $0.28 and a 52-week high of $0.59. The firm’s 50-day moving average price is $0.41 and its 200 day moving average price is $0.39.

Insider Buying and Selling by Quarter for Repro-Med Systems (NASDAQ:REPR)

About Repro-Med Systems

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

5 Day Chart for NASDAQ:REPR

Receive News & Stock Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related stocks with our FREE daily email newsletter.